Inozyme Pharma
Price & Volume
Stats
See moreOpen | $1.24 |
Previous Close | $1.25 |
Day Range | $1.21-$1.29 |
52W Range | $1.23-$7.79 |
Market Cap | $80.3M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.55 |
News
See moreYahoo Finance • 3 days ago
Inozyme Pharma to Present Recently Announced Interim Data for INZ-701 in Infants and Young Children with ENPP1 Deficiency at CHOP Cardiology 2025
Yahoo Finance • last year
Inozyme Pharma to Participate in Upcoming Investor Conferences
Yahoo Finance • last year
Inozyme Pharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights
Yahoo Finance • last year
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Dr. Douglas A. Treco Ph.D. |
CFO | Mr. Sanjay S. Subramanian M.B.A., M.S. |
Address | 321 Summer Street, Boston, MA, United States, 02210 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 59 |
